NICE approves GSK's lupus drug Benlysta

The National Institute for Health and Care Excellence (NICE) has reportedly approved GlaxoSmithKline's (GSK) Benlysta for the treatment of lupus.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news